August 3, 2022

Restoring the Retina: How to Regenerate Photoreceptors in Inherited Retinal Dystrophy

Notch pathway inhibition preserves retinal neurons and promotes regrowth in zebrafish

22-EYE-3049477 New findings in retinal regeneration-Perkins-650×450-4

Unlike humans and other mammals, zebrafish have the ability to activate stem cells to regenerate retinal neurons killed by high-intensity light damage or injury. After being blasted with light, lost or damaged photoreceptors in zebrafish regrow. So, why doesn’t the same thing happen when zebrafish photoreceptors degenerate due to disease?

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

A team led by ophthalmic researcher Brian Perkins, PhD, of Cleveland Clinic Cole Eye Institute has discovered that it can. Their findings were published recently in the Journal of Neuroscience.

“Ours is one of the first studies that uses a disease model of progressive retinal dystrophy to understand retinal regeneration,” says Dr. Perkins. “Physicians typically aren’t seeing patients who forgot to wear sunglasses and stared at the sun for 20 minutes. They’re treating patients with retinitis pigmentosa; macular degeneration; and slow, progressive inflammatory responses and diseases.”

The retina in zebrafish regenerates following light damage. Cone photoreceptors are shown in yellow/cyan. Active stem cells are in magenta. At three days post injury (3 dpi), the photoreceptors have been completely destroyed. At 30 days post injury (30 dpi), they have been completely regenerated.

Findings shine a light on slow disease models

In a zebrafish model of inherited retinal dystrophy, Dr. Perkins’ team used single-cell RNA sequencing to dissociate cells in the retina and sequence genes that were turning on in individual cells.

“We found that in the Müller glia — which can act as endogenous stem cells in the retina — the expression of one particular gene called notch3 was enhanced,” Dr. Perkins explains. “Previous research had shown that following light damage, expression of notch3 was decreased.”

Advertisement

Those contrasting findings suggested that inhibiting the Notch pathway would send the regeneration process into overdrive. Dr. Perkins’ research team proved it by using a notch3-inhibiting drug to trigger regeneration, leading to a complete preservation of photoreceptors.

“In these disease models, it was the enhancement of Notch signaling that was preventing zebrafish from regenerating photoreceptors,” Dr. Perkins says.

Mitigating inflammation slows retinal degeneration

The team also reported that immunosuppression mitigated the effects of retinal degeneration.

By breeding the zebrafish model of inherited retinal dystrophy with a second zebrafish mutant that lacked immune cells in the eye, the team developed fish that carried a mutation for retinal degeneration but no inflammation. In those fish, the photoreceptors did not degenerate despite having the mutation.

While there’s still debate about the utility of immunosuppressants in people with inherited retinal dystrophy, Dr. Perkins says his findings support the idea that reducing inflammation slows degeneration of photoreceptors.

Advertisement

Next steps: Generalizing the findings to other genetic models

Dr. Perkins plans to continue researching the link between inflammation and Notch signaling. He and his team hope to show similar findings in other disease models.

“There’s a lot left to explore,” he says. “We looked at one particular genetic model. We fully expect this to be generalized, but we need to confirm it.”

The team also intends to look more closely at single-cell RNA sequencing and uncover other gene expression changes that are occurring.

“We plan to further study how other pathways are responding differently in disease models compared to injury models,” says Dr. Perkins. “There’s a solid and deep foundation for what happens following light damage or acute injury, but that’s not necessarily transferable to a slow disease state.”

Related Articles

23-EYE-4196362-inflammation-retinal-regeneration-CQD-Hero
September 19, 2023
Could Inflammation Be the Reason Why Human Retinas Don’t Regenerate?

Researchers to study retinal regeneration in zebrafish with new grant from National Eye Institute

23-EYE-4051658-CQD-ChatGPT-in-Ophthalmology-Research
August 14, 2023
Don’t Believe Everything Chatbots Say About Ophthalmic Research

30% of references generated by ChatGPT don’t exist, according to one study

22-EYE-3391159 CQD-Treating Retinoschisis-hero
December 23, 2022
Long-Term Topical Dorzolamide Improves Visual Acuity in Juvenile X-Linked Retinoschisis

Study followed patients an average of eight years

22-EYE-3066210 CQD-Losartan for corneal fibrosis-Wilson-hero
September 7, 2022
Hypertension Drug Losartan Reverses Scarring and Restores Vision After Cornea Damage

Studies indicate dramatic results when used topically with or without corticosteroids

22-EYE-3141638 CQD-EYP-1901 with vorolanib for maintenance of nAMD
August 23, 2022
DAVIO Trial Results: Vorolanib Injection Reduces Treatment Burden for Patients with nAMD

53% of participants didn’t need anti-VEGF for six months or longer

22-EYE-2952199 CQD-Fixation eye movement abnormalities in amblyopia-Ghasia-650×450
July 29, 2022
Amblyopia: Eye Movement Recordings Enhance Understanding of Visual Deficits

Patients frequently have problems with depth perception and interocular suppression

A Cleveland Clinic Cole Eye Institute ophthalmologist uses intraoperative OCT during retinal surgery.
June 24, 2022
3D Viewing System Improves Surgical-Field-Based Visualization of iOCT Data

Surgeons also report benefits of integrated heads-up display

22-EYE-2826711 CQD_fig 1_Cornea Service – Grants_650x450_hero
June 7, 2022
Nine NIH R01 and Equivalent Grants Help Cleveland Clinic Researchers Advance Cornea Care

Among latest findings: Topical losartan helps reduce corneal scarring after injury

Ad